Furthermore, we identified significant positive correlations between NEAT1 and CCL2, and IL-6, which may explain its pathological role in COVID-19 by targeting CCL2 and IL-6 and increasing their production, specifically in the severe form of the disease. This evidence concerns the gene CCL2 and COVID-19.